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Abstract 
Hemiplegic migraine is a rare and complex disease, characterized by migraine with a reversi-
ble motor aura. Hemiplegic migraine can be easily misdiagnosed at its first presentation with 
an atypical severe form of migraine, a stroke, multiple sclerosis, metabolic disorders, conver-
sion disorder or an epilepsy. We present the case of a young 24-year-old male patient, who 
since the age of 4 years had been having multiple episodes of migraine associated with hem-
iparesis, paraesthesia, prolonged somnolence, aphasia and confusion. We review the litera-
ture and discuss important diagnostic findings in hemiplegic migraine to help establishing a 
prompt diagnosis. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Migraine is a common health condition, with an estimated prevalence of 6% among men 
and 16% among women [1]. However, prompt diagnosis can be difficult given the multiple 
and rare forms of migraine; in these cases, treatment is frequently delayed at the expenses of 
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type of migraine typically presenting with a reversible not isolated motor aura (hemiplegia) 
associated with other neurological symptoms, such as seizure and coma [2, 3]. HM is differ-
entiated into two main clinical subgroups, i.e. familial hemiplegic migraine (FHM) and spo-
radic hemiplegic migraine. Both have similar clinical symptoms, except the latter is without 
familiarity [3]. The prevalence of FHM is low (0.005%) [4]. FHM is a genetically heterogene-
ous condition. Mutations in four different genes, each characterizing the four familial forms 
(CACNA1A/FHM1, ATP1A2/FHM2, SCN1A/FHM3, PRRT2/FHM4) were identified; these 
genes are involved in encoding ion transporter proteins [5, 6]. These mutated genes are the 
cause of an altered neuronal excitability and reduced threshold value for cortical spreading 
depression (CSD), a transient slow wave of profound neuronal and glial depolarization, 
which spreads over the brain hemispheres or in certain cases affects the brain stem being 
responsible for the brain stem symptoms in FHM; CSD is also supposed to be responsible for 
the migrainous aura in HM [4, 7]. 
Case Presentation 
A 24-year-old male presented with multiple episodes of migraine associated with hemi-
paresis, paraesthesia, prolonged somnolence, aphasia and confusion, which he had been 
having since the age of 4 years. He did not report visual disturbances or dysarthria. Each 
episode was characterized by a progressive reduction of symptoms and a full recovery. He 
was an only child. His father presented with some episodes of migraine, which, however, 
were never associated with other symptoms. Also, his grandmother (of paternal origin) had 
uncomplicated episodes of migraine. His family history was otherwise unremarkable. The 
patient had 2 episodes of migraine per week. The patient was extremely somnolent after 
these episodes (up to 24–48h). Several admissions to the intensive therapy unit were neces-
sary. Given the 20-year history of stereotyped episodes, migraine with aura and epilepsy 
needed to be considered foremost. Repeated brain imaging (including also MRI angiog-
raphy) were normal. Routine laboratory studies were within normal limits, anti-limbic en-
cephalitis and NMDA-receptor antibody encephalitis were negative, and lumbar puncture 
was unremarkable. His electroencephalography (EEG) recording (fig. 1) showed significant 
changes, for his age, in form of an atypical diffuse slowing (within the delta/theta range) 
particularly over the left frontoparietal region corresponding to the 3-day- lasting period of 
somnolence. No epileptiform alterations were present. Analgesics and lamotrigine 50 mg 
twice daily, subsequently increased to lamotrigine 100 mg twice daily, were prescribed. The 
patient remained complain-free for several years with normalized EEG at follow-up visits 
(fig. 2) until he presented again with a migraine attack with hemiparesis. Lamotrigine was 
reduced progressively and replaced by increasing doses of topiramate (since then the pa-
tient is free of symptoms). Despite the negative family history for HM, we conducted genetic 
testing. The patient had the mutation c.2936C>T in the gene ATP1A2. This mutation is due to 
a substitution of a proline to a leucine in the codon 979 (p.Pro979Leu). This mutation is 
known; his father did not have the mutation. Paternity testing was not done. 
Discussion 
HM is a rare and complex disease characterized by migraine with a reversible motor au-
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headache (bi- or unilateral, ipsi- or contralateral to the motor weakness) can start before or 
after the aura [3]. HM is differentiated into FHM and sporadic HM, according to the presence 
or absence of familiarity [3]. HM can be easily misdiagnosed at its first presentation as an 
atypical severe form of migraine, a stroke, multiple sclerosis, metabolic/toxic disorders, con-
version disorder or an epilepsy (Jacksonian march, Todd’s paralysis) [4, 9]. The clinical diag-
nosis is also rendered difficult, as migraine, epilepsy and HM share not solely clinical, but 
also pathophysiological similarities. It is supposed that migraine attacks, epilepsy and HM 
might be due to neuronal cortical hyperexcitability [2, 10, 11]. Vanmolkot et al. [11] showed 
that approximately 75% of HM families have a mutation in CACNA1A (in FHM1) and that 
some CACNA1A mutations may also cause epilepsy. Penetrance of epilepsy can range be-
tween 30 and 60% in some FHM2 families [3]. These findings may explain why antiepileptic 
medication, such as topiramate and valproate, which suppress CSD, can be equally beneficial 
in the treatment of HM [10]. 
Over the last 10 years, there have been several reports on this disease. Weng et al. [4] 
reported the case of a 24-year-old male student who presented with general weakness that 
subsequently shifted to the right side associated with throbbing headache, right-sided hemi-
anesthesia, hemianopia and facial palsy. Brain imaging (CT) was normal. The diagnosis of 
FHM was made based on similar previous attacks and a positive family history. Acetamino-
phen and flunarizine were prescribed during hospitalization and, for prophylaxis, verapamil. 
The symptoms subsided gradually without sequelae. Genetic testing was not performed. 
Merwick et al. [6] reported the case of a 32-year-old woman with known FHM (ATP1A2 mu-
tation) who presented in an acute confusional state after she had suffered an HM attack and 
was suspected initially to have an infectious encephalitis. Her EEG showed (similar to our 
patient) slowing of alpha rhythm and continuous rhythmical delta-theta activity in the left 
hemisphere. She recovered 48 h after the episode with a normalization of her EEG. 
Ambrosini et al. [7] described the case of a 15-year-old boy with recurrent attacks start-
ing with an aura characterized by visual symptoms, unilateral paraesthesias, which lasted 
less than 15 min, followed by unilateral pulsating headache with a duration of approximately 
6 h. Interictal neurologic examination, brain imaging (MRI) and EEG were reported to be 
normal. Family history was remarkable for similar episodes presenting in the patient’s fa-
ther and uncle. Also, the patient’s cousin and mother were affected by migraine, but without 
aura. Genetic testing was positive for ATP1A2 mutation in the patient. A diagnosis of basilar 
migraine was made, but the authors underlined that basilar migraine and FHM are ‘linked 
not only on a clinical basis, but also on a pathogenetic one’. In 2014, Tashiro et al. [12] pub-
lished a case on a 38-year-old man with recurrent migraine attacks with aura, sometimes 
associated with hemiparesis. He had suffered from these attacks since his teenage years. 
Family history revealed that his mother suffered equally from migraines with hemiparesis. 
Based on the patient and family history findings, a clinical diagnosis of FHM was made. Sub-
sequently, genetic testing showed that the patient and his mother had a mutation in the 
CACNA1A gene. Sodium valproate was prescribed, and the patient remained free of symp-
toms. 
Diagnosis of FHM can be delayed because obtaining a detailed description of the clinical 
course, spanning years that included migraine episodes associated with a motor deficit [3], 
in the emergency department can be difficult; even during follow-up visits, patients or family 
members can miss to recall that some headache episodes occurred with motor deficits [3]. 
Russel and Ducros [3] reported that alterations of consciousness (ranging from confusion to 
somnolence to coma) are ‘frequently, but not always associated with motor deficits’. There-
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nolence, a wide range of differential diagnoses need to be considered. Multiple conditions 
that can present with prolonged somnolence with EEG slowing need to be taken into consid-
eration, such as space-occupying lesions (e.g. tumor of the pineal gland, hypothalamus), 
meningitis, encephalitis, a metabolic encephalopathy, drug intoxication, hypoxic states, mul-
tiple sclerosis, intracranial hemorrhage (especially when related to trauma, as in our pa-
tient) and an internal carotid artery thrombosis (to be considered by the association be-
tween hemiplegia and slow-wave EEG activity). An exhaustive diagnostic workup including 
brain imaging, a lumbar puncture, EEG and blood testing are critical.  
Further, the diagnosis of FHM in our patient was made more difficult as there was no 
family history for HM; a similar case was described in the literature. Ohmura et al. [13] re-
ported a case of a patient with sporadic hemiplegic migraine, who nevertheless presented 
with a CACNA1A mutation. 
An important diagnostic finding in HM helping to differentiate classical migraine from 
HM is that the motor aura in HM is never isolated, but associated with sensory, language or 
visual symptoms [3]. Our patient presented with recurrent headaches and reversible motor 
deficits, which were associated with aphasia, prolonged somnolence and confusion. A fur-
ther important differentiation factor between HM and classical migraine with aura is that 
minor head trauma can trigger HM [3], whereas minor head trauma is not a triggering factor 
of classical migraine with aura. A careful anamnesis showed that our patient had indeed 
suffered on three occasions a hemiparesis after a fall. 
Conclusion 
Migraine, albeit transitory, is a highly disabling condition that can present in multiple 
forms. Correct diagnosis is critical to initiate prompt treatment. A rare form of migraine is 
HM. Within the plethora of clinical presentations of HM, HM should be considered when the 
migraine aura is not isolated and associated with other symptoms. Also, multiple episodes of 
migraine associated with recurrent reversible encephalopathy (triggered by minor head 
trauma), should raise the suspicion of HM and prompt further diagnostic workup, which 
should always include genetic testing. Prompt diagnosis in the emergency setting is difficult 
as patients can present with language difficulties and the history taken is seriously ham-
pered. Detailed family history and third-party anamnesis are critical in establishing the di-
agnosis. As HM shows a high phenotypic variability, clinicians should always keep a high 
clinical suspicion of HM in every unusual presentation of migraine. 
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Fig. 1. The EEG trace is showing a postictal diffuse slowing in the delta-theta activity particularly over the 
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Fig. 2. The EEG at follow-up is showing a normalized trace with a temporo-occipital prominent alpha ac-
tivity. 
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